ClinicalTrials.gg
Status unknownNCT05554809Updated Sep 26, 2022

Unilateral Stretch Crossover Effect RCT

An interventional study of Strecthing in Muscle Tightness and Stretch, sponsored by Luleå Tekniska Universitet. Status unknown at 1 site in Sweden. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-26.

Sponsored by Luleå Tekniska Universitet · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Sep 2022), so the status shown — last known as Enrolling by invitation — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
69
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The crossover-effect within resistance- and strength training is more or less confirmed with multiple studies showing similar results. The studies shows an increase in muscle strength within the contralateral extremity being exercised. Regarding muscle length or mobility (flexibility) the crossover-effect have not been studied.

For a person to gain an increase in muscle strength mobility training in the form of stretching and flexibility training of our skeletal muscle is a common exercise. However, the evidence are scare and there are only a few studies comparing the effect of prolonged static stretching (> 90 sec) and dynamic flexibility training as to which of these methods has the best length-enhancing effect over time.

The purpose of this study is to compare the crossover-effect of eight weeks of oneleg dynamic flexibility training versus oneleg prolonged static stretching versus a nonstretching controlgroup on mobility in the hamstring muscles in adults with reduced mobility of the hamstring muscle. The aim is also to compare the sustained effect of flexibility training between the two groups, eight weeks after completion of the intervention.

02

Conditions studied

  • Muscle Tightness
  • Stretch
03

In context

Lead sponsor

Luleå Tekniska Universitet is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Passiv straigth leg raise \< 70 degrees
  • Read and understand swedish

Exclusion criteria

Exclusion Criteria:

  • Injuries within the hamstrings muscle past 3 month
  • Disabilities within the muscloskeletal system (i.e. lower back, thoracic spine, cervikal spine, hip, knee, ankle, fot) affecting the participants life
  • Neurological, inflammatoric or heart-diseases
  • Nociplasic pain disorders
  • Medication with possibility affecting muscle strength of flexibility
  • Positive neurodynamic test of the lower extremity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
69 participants (estimated)

Study arms

  • Experimental
    Dynamic stretching

    Other: Strecthing

  • Experimental
    Static stretching

    Other: Strecthing

  • Active comparator
    Controll

    Other: Strecthing

Interventions

  • OtherStrecthing

    Comparing the crossover-effect of dynamic versus static stretching

06

What researchers measure

Primary outcomes

  1. Passiv straigth leg raising

    Muscle length of the hamstrings muscle will be measured via degress of hip flexion at a passive straigth leg raise of the lower extremity. One leg at a time.

    Time frame: 5 minutes

  2. Active knee extension

    The person will lay supine with a 90 degress of hip flexion towards a bar against the thigh. Thereafter the person will perform an active knee extensor as far as possible and the degrees of kneeflexion will be measured.

    Time frame: 5 minutes

07

Study locations

1 site
  • Luleå university of Technology
    Luleå, Norrbotten 97187, Sweden
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2022 (actual). Primary completion is estimated for Jun 2023, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2022
First posted
Sep 26, 2022
StartActual
Sep 15, 2022
Primary completionEst.
Jun 1, 2023
CompletionEst.
Jun 1, 2023
Last update
Sep 26, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05554809
Lead sponsor
Luleå Tekniska Universitet
Responsible party
Sponsor
First posted
Sep 26, 2022
Start date
Sep 15, 2022
Primary completion
Jun 1, 2023 (estimated)
Completion
Jun 1, 2023 (estimated)
Last update
Sep 26, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion